1. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, and Leonard WJ (1996). cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 271: 29265–29270.
2. Angevin E, Glukhova L, Pavon C, Chassevent A, Terrier-Lacombe MJ, Goguel AF, Bougaran J, Ardouin P, Court B-H, Perrin JL, Vallancien G, Triebel F, and Escudier B (1999). Human renal cell carcinoma xenografts in SCID mice: Tumorigenicity correlates with a poor clinical prognosis. Lab Invest 79: 879–888.
3. Bossù P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G, Del Grosso E, Tagliabue A, and Boraschi D (1995). Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am J Pathol 147: 1852–1861.
4. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, and Ferrara P (1996). Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271: 16921–16926.
5. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, and Mantovani A (1993). Interleukin-1 type II receptor: A decoy receptor for IL1 that is regulated by IL-4. Science 261: 472–475.